Officina Farmaceutica Italiana

Officina Farmaceutica Italiana (OFI) is a leading Italian Contract Development and Manufacturing Organization (CDMO) specializing in the creation, development, and production of dermo-cosmetics, dietary food supplements, and medical devices. Founded in 1946 and headquartered in Bergamo, Italy, the company provides full-service solutions including formulation R&D, regulatory consulting, quality assurance, and advanced manufacturing. OFI operates state-of-the-art, highly automated facilities and is certified as a B Corp, reflecting its commitment to sustainability and high-quality standards. In 2020, OFI was acquired by Procemsa (now rebranded as Ourvita), a portfolio company of Investindustrial, to form a major international player in the health and wellness CDMO sector.